Batu Biologics Reaches 50% Of Crowdfunding Goal
7/8/2014 11:20:47 AM
SAN DIEGO--(BUSINESS WIRE)--Batu Biologics announced today that the company successfully rose over 50% of its crowdfunding target to assist in completion of preclinical studies to support the FDA submission of its novel cancer vaccine, ValloVax™. On June 18th, 2014 Batu Biologics announced the launch of its Indiegogo campaign seeking to raise $100,000, which can be viewed online at the following link: https://www.indiegogo.com/projects/emerging-lung-cancer-vaccine-targets-tumor-blood-vessels-introducing-vallovax
Help employers find you! Check out all the jobs and post your resume.
comments powered by